Benefit or toxicity from neurologically targeted antiretroviral therapy?
Brew
Bruce J
BJ
D015526:AIDS Dementia Complex / Q000517:prevention & control*; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D009483:Neuropsychological Tests
D019380:Anti-HIV Agents